Where Things Stand Now

Since TrumpRx launched in February 2026, the program has steadily expanded — and as of this past week, the site now lists over 800 medications after the administration added more than 600 generic drugs to the catalog.

Trump made the announcement at a Monday event, saying his team was "adding over 600 affordable generics to the website" and calling TrumpRx "one source to ensure that they are getting the lowest possible cost on their prescription," according to The Guardian.

What's New on the Site

Joe Gebbia — co-founder of Airbnb and Trump's chief design officer — showed off new features at the event. The site now includes a "Presidential Deals" section featuring discounted brand-name drugs. Consumers can also compare brand-name drugs against generic alternatives, according to The Guardian.

Gebbia pitched a new price-comparison tool as the main upgrade: "Now you can compare for the best medicine prices, as easy as it is to compare hotels or Airbnbs or baseball tickets."

There's also a planned feature — NOT live yet — that would connect patients with the lowest-price pharmacy nearby or let them order discounted drugs shipped directly to their homes, according to AP News.

The original TrumpRx catalog drew immediate criticism for being too narrow to help most patients.

What the Experts Are Actually Saying

Sean Sullivan — professor of health economics and policy and former dean of pharmacy at the University of Washington — told The Guardian earlier this year: "Consumers can probably get a cheaper version of these medicines through insurance and their pharmacies, or via cash pay services like Cost Plus Drugs than by the deals offered through TrumpRx."

Sullivan is a pharmacist and health economist assessing the program on its merits.

Rena Conti, an associate professor of markets, public policy and law at Boston University's Questrom School of Business, echoed those concerns, telling The Guardian that American healthcare is "really complicated" and a single website isn't going to cut through that complexity for most patients.

Sullivan and Conti's point is specific: for patients WITH insurance, TrumpRx probably doesn't beat what they already have. For the uninsured, Cost Plus Drugs — Mark Cuban's platform — is already doing what TrumpRx is trying to do, and has been for years.

What Mainstream Coverage Is Missing

Left-leaning outlets are framing this as Trump slapping his name on an existing tool and calling it a revolution. That's partially fair — but they're glossing over something real: the uninsured and underinsured DO face brutal prescription drug prices, and any tool that helps comparison shop is net positive.

Right-leaning coverage is treating this like a solved problem. It isn't. The site's limitations are real. If TrumpRx's generic prices don't actually undercut GoodRx, Cost Plus Drugs, or basic insurance copays, then the "sevenfold expansion" is a marketing story, not a healthcare story.

No mainstream outlet has published a direct price comparison. Not one pulled up a basket of common generics — metformin, atorvastatin, lisinopril — and compared TrumpRx prices against GoodRx or Cost Plus. A drug-by-drug price test is what matters.

For Different Patient Groups

If you have employer-sponsored insurance: TrumpRx probably doesn't help you. Your copays and formulary pricing are almost certainly competitive or better.

If you're uninsured or on a high-deductible plan: check TrumpRx alongside GoodRx and Cost Plus Drugs before filling anything. Competition between these platforms is real, and the best price will vary by drug and location.

If you're on a brand-name drug with no generic equivalent: the "Presidential Deals" section is worth checking — but don't hold your breath. Brand-name drug pricing in America is a systemic problem that a government website doesn't solve.

The administration deserves credit for building something and iterating on it. 800 drugs is better than 130. Price comparison tools are useful.

Until someone publishes a real apples-to-apples price test — drug by drug, pharmacy by pharmacy — TrumpRx remains an assertion, not a proven bargain.